Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels
Life Sciences · 2026-08 · 398 · 124467
DOI: 10.1016/j.lfs.2026.124467 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-08. Verfasst von Carolina Victoria Cruz Junho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; Institute of Physiology II, …. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Extracellular Traps, Inflammation, Serum Albumin, Bovine. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim Foundation, RWTH Aachen University Faculty of Medicine, RWTH Aachen University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; Institute of Physiology II, University of Münster, Münster, Germany. Electronic address: carolina.…
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; Physical Examination Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, M…
- Institute for Transfusion Medicine and Cell Therapeutics, University Hospital RWTH Aachen, Aachen, Germany.
- Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; Aachen-Maastricht Institute for Cardiorenal Disease (AMICARE), RWTH Aachen Campus, Aachen, Germany…
Förderung
- Boehringer Ingelheim Foundation
- RWTH Aachen University Faculty of Medicine
- RWTH Aachen University
- European Foundation for the Study of Diabetes
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- Alexander von Humboldt-Stiftung
- German Center for Cardiovascular Disease
- Boehringer Ingelheim
Zitieren
APA
Junho, C. V. C., Dai, Y., Schieren, L., Hourtz, S., Rykova, T., Vondenhoff, S., Wessiepe, M., Zou, J., Jankowski, J., Goettsch, C., & Noels, H. (2026). Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels. Life Sciences, 398, 124467. https://doi.org/10.1016/j.lfs.2026.124467
Vancouver
Junho CVC, Dai Y, Schieren L, Hourtz S, Rykova T, Vondenhoff S, et al. Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels. Life Sciences. 2026;398:124467. doi:10.1016/j.lfs.2026.124467
BibTeX
@article{Junho2026,
author = {Junho, Carolina Victoria Cruz and Dai, Yusang and Schieren, Luisa and Hourtz, Sina and Rykova, Tetiana and Vondenhoff, Sonja and Wessiepe, Martina and Zou, Jinmi and Jankowski, Joachim and Goettsch, Claudia and Noels, Heidi},
title = {Advanced glycation end product (AGE)-modified albumin does not enhance neutrophil extracellular trap formation and minimally impacts endothelial inflammation in large vessels},
journal = {Life Sciences},
year = {2026},
volume = {398},
pages = {124467},
doi = {10.1016/j.lfs.2026.124467}
}
EUVIMED